Kalydeco is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Vertex Pharmaceuticals Incorporated. The primary component is Ivacaftor.
| Product ID | 51167-600_35644d47-5161-4a5e-8c5c-04b0a9a201e5 |
| NDC | 51167-600 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Kalydeco |
| Generic Name | Ivacaftor |
| Dosage Form | Granule |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-04-29 |
| Marketing Category | NDA / NDA |
| Application Number | NDA207925 |
| Labeler Name | Vertex Pharmaceuticals Incorporated |
| Substance Name | IVACAFTOR |
| Active Ingredient Strength | 25 mg/1 |
| Pharm Classes | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC],Chloride Channel Activation Potentiators [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2019-04-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA207925 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-04-29 |
| Ingredient | Strength |
|---|---|
| IVACAFTOR | 25 mg/1 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 51167-200 | Kalydeco | ivacaftor |
| 51167-300 | Kalydeco | ivacaftor |
| 51167-400 | Kalydeco | ivacaftor |
| 51167-600 | Kalydeco | ivacaftor |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() KALYDECO 85585659 4245428 Live/Registered |
Vertex Pharmaceuticals Incorporated 2012-03-31 |
![]() KALYDECO 85155478 4147369 Live/Registered |
Vertex Pharmaceuticals Incorporated 2010-10-18 |